☆ 4.1 Review

Managing Survivorship after Hematopoietic Cell Transplantation

CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2023)

Related references

Note: Only part of the references are listed.

Article Biophysics

Life expectancy and burden of late complications after reduced intensity conditioning allogeneic transplantation

Aurelien Sutra Del Galy et al.

Summary: Reduced intensity conditionings (RIC) before and after allogeneic hematopoietic stem cell transplantation (HSCT) allow older or unfit patients to undergo transplantation, but little is known about survival expectancy and burden of late complications. This study aimed to describe the long-term outcomes in patients who received HSCT following RIC. The results showed that late survivors after RIC require long-term follow-up and active intervention to prevent cardiovascular disease and screen for cancers.

BONE MARROW TRANSPLANTATION (2022)

Add to Collection

Article Hematology

Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life

Knut Smeland et al.

Summary: This study assessed the late effect burden and its impact on health-related quality of life (HRQoL) in lymphoma survivors after high-dose therapy with autologous stem-cell transplant (HDT-ASCT). The majority of survivors had moderate or more severe late effects, which negatively affected their physical and mental HRQoL. The findings highlight the importance of prevention, early detection, and treatment of late effects in this population.

HAEMATOLOGICA (2022)

Add to Collection

Article Health Care Sciences & Services

Long-term effects after stem cell transplantation identified: design of the MOSA study

Bianca Wauben et al.

Summary: The MOSA study aims to compare the adverse health effects in hematopoietic stem cell transplantation survivors with the general population, and provide essential information through comparison with a reference group. The study uses the same protocol and phenotyping measurements, with the goal of improving screening and prevention strategies.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2022)

Add to Collection

Article Oncology

Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study

Saro H. Armenian et al.

Summary: This study reveals that AML survivors who underwent blood or marrow transplantation have a significantly higher risk of severe/life-threatening conditions compared to unaffected siblings, including subsequent neoplasms, diabetes, cataracts, venous thromboembolism, and joint replacement.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Review Immunology

Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy Recipients

Jennifer M. Knight et al.

Summary: This article emphasizes the importance of biobehavioral processes for clinical outcomes among transplantation and cellular therapy (TCT) patients, especially during the Covid-19 pandemic. Stress and adverse psychosocial factors can affect the immune and neuroendocrine systems, leading to symptoms such as depression, fatigue, sleep disturbances, and cognitive dysfunction. The article also discusses the implications for specific populations and addresses protective psychological processes that may optimize biobehavioral outcomes.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Biophysics

Survivorship care for allogeneic transplant patients in the UK NHS: changes centre practice, impact of health service policy and JACIE accreditation over 5 years

Fiona L. Dignan et al.

Summary: Despite improvements in long-term follow-up services for allogeneic transplant recipients in UK driven by health service policies and JACIE accreditation standards, there are still deficiencies in psychological support, vaccinations, and cancer screening. Variations in practice between different transplant centers persist.

BONE MARROW TRANSPLANTATION (2021)

Add to Collection

Article Oncology

Clinical, social, and psycho-oncological needs of adolescents and young adults (AYA) versus older patients following hematopoietic stem cell transplantation

Kristin Pulewka et al.

Summary: The study found that there are differences in medical, psychological, and social needs between adolescents and young adults as well as older patients after HSCT, indicating the importance of age-appropriate informational materials to meet these diverse needs.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

Add to Collection

Article Hematology

Comorbidity profile of adult survivors at 20 years following allogeneic hematopoietic cell transplantation

Ayesh K. Seneviratne et al.

Summary: This study reviewed comorbidities in allogeneic HCT recipients surviving 20 years post-transplantation, finding dyslipidemia, hypertension, osteoporosis, hypothyroidism, and depression/anxiety as the most common comorbidities. The number of comorbidities was shown to have a significant impact on overall survival in these long-term survivors.

EUROPEAN JOURNAL OF HAEMATOLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Lipodystrophy as a Late Effect after Stem Cell Transplantation

Daniel Tews et al.

Summary: HSCT-associated lipodystrophies may be seen as a novel form of acquired lipodystrophy.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Oncology

Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and Mechanisms

Rebecca A. Harrison et al.

Summary: Hematopoietic stem cell transplant (HSCT) is crucial in treating hematologic cancers, but can lead to cognitive impairment and other challenges for survivors. Understanding the impact on brain health is essential for clinicians working with HSCT survivors, as it can affect various aspects of their lives. Efforts to identify and manage cognitive dysfunction and related symptoms are important for managing the long-term effects of HSCT.

ONCOLOGIST (2021)

Add to Collection

Article Hematology

Gut Microbiota Dysbiosis Associated with Persistent Fatigue in Hematopoietic Cell Transplantation Survivors

Nosha Farhadfar et al.

Summary: Fatigue is a common and distressing complication among hematopoietic stem cell transplantation survivors, linked to chronic systemic inflammation and changes in gut microbiota composition. This study found significant differences in gut microbiota composition between HCT survivors with and without persistent fatigue, highlighting a potential microbial contribution to clinically significant fatigue post-transplantation.

TRANSPLANTATION AND CELLULAR THERAPY (2021)

Add to Collection

Article Hematology

Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of Life

George E. Georges et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)

Add to Collection

Article Hematology

Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases

Justine M. Kahn et al.

BLOOD ADVANCES (2020)

Add to Collection

Article Hematology

Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia

Catherine J. Lee et al.

BLOOD ADVANCES (2020)

Add to Collection

Article Hematology

Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life

Knut Smeland et al.

HAEMATOLOGICA (2020)

Add to Collection

Article Hematology

Vascular Structure and Function in Cancer Survivors after Hematopoietic Stem Cell Transplantation

Donald R. Dengel et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)

Add to Collection

Article Oncology

Premature Aging in Young Cancer Survivors

Saro H. Armenian et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)

Add to Collection

Article Hematology

Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors

Navneet S. Majhail et al.

HAEMATOLOGICA (2019)

Add to Collection

Article Hematology

Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell Transplantation

Linda J. Burns et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)

Add to Collection

Article Hematology

ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors

Shahrukh K. Hashmi et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)

Add to Collection

Article Oncology

An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation

Karen L. Syrjala et al.

JOURNAL OF CANCER SURVIVORSHIP (2018)

Add to Collection

Article Oncology

Coming of Age With Cancer: Physical, Social, and Financial Barriers to Independence Among Emerging Adult Survivors

Eden R. Brauer et al.

ONCOLOGY NURSING FORUM (2018)

Add to Collection

Article Oncology

Setting the stage for universal financial distress screening in routine cancer care

Nandita Khera et al.

CANCER (2017)

Add to Collection

Article Hematology

Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT

Andrew C. Dietz et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)

Add to Collection

Article Hematology

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report

Margaret Bevans et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)

Add to Collection

Article Hematology

Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation

Aline Clavert et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)

Add to Collection

Article Hematology

Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report

Eric J. Chow et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)

Add to Collection

Article Oncology

Perceived social support and health-related quality of life in AYA cancer survivors and controls

Marta Tremolada et al.

PSYCHO-ONCOLOGY (2016)

Add to Collection

Article Hematology

Prevalence of Hematopoietic Cell Transplant Survivors in the United States

Navneet S. Majhail et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)

Add to Collection

Article Biophysics

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation

N. S. Majhail et al.

BONE MARROW TRANSPLANTATION (2012)

Add to Collection

Article Oncology

Nonmalignant Late Effects and Compromised Functional Status in Survivors of Hematopoietic Cell Transplantation

Nandita Khera et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

Add to Collection

Article Oncology

Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation

John R. Wingard et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Add to Collection

Article Hematology

Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns

F. Lennie Wong et al.

BLOOD (2010)

Add to Collection

Article Oncology

Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation

Paul J. Martin et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Add to Collection

Article Hematology

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study

Smita Bhatia et al.

BLOOD (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.